Millennium Management
BEAM icon

Millennium Management’s Beam Therapeutics BEAM Stock Holding History

Millennium Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$530K Sell
22,234
-279,416
-93% -$7.75M ﹤0.01% 4737
2025
Q4 		$8.36M Buy
301,650
+271,900
+914% +$6.94M ﹤0.01% 2454
2025
Q3 		$722K Sell
29,750
-28,454
-49% -$566K ﹤0.01% 4854
2025
Q2 		$990K Buy
58,204
+21,724
+60% +$378K ﹤0.01% 4419
2025
Q1 		$712K Sell
36,480
-38,873
-52% -$1.02M ﹤0.01% 4595
2024
Q4 		$1.87M Sell
75,353
-6,364
-8% -$162K ﹤0.01% 3701
2024
Q3 		$2M Buy
81,717
+873
+1% +$22.6K ﹤0.01% 3701
2024
Q2 		$1.89M Sell
80,844
-26,343
-25% -$647K ﹤0.01% 3585
2024
Q1 		$3.54M Buy
107,187
+31,478
+42% +$981K ﹤0.01% 3222
2023
Q4 		$2.06M Sell
75,709
-67,722
-47% -$1.68M ﹤0.01% 3577
2023
Q3 		$3.45M Sell
143,431
-52,100
-27% -$1.4M ﹤0.01% 3066
2023
Q2 		$6.24M Buy
195,531
+2,531
+1% +$82.1K ﹤0.01% 2455
2023
Q1 		$5.91M Buy
193,000
+113,846
+144% +$4.49M ﹤0.01% 2455
2022
Q4 		$3.1M Sell
79,154
-88,951
-53% -$3.98M ﹤0.01% 3198
2022
Q3 		$8.01M Sell
168,105
-232,258
-58% -$13.2M ﹤0.01% 2422
2022
Q2 		$15.5M Sell
400,363
-177,698
-31% -$7.06M 0.01% 1552
2022
Q1 		$33.1M Buy
578,061
+437,411
+311% +$28.7M 0.02% 951
2021
Q4 		$11.2M Sell
140,650
-86,339
-38% -$7.39M 0.01% 2023
2021
Q3 		$19.8M Buy
226,989
+131,294
+137% +$13.2M 0.01% 1338
2021
Q2 		$12.3M Sell
95,695
-98,600
-51% -$7.86M 0.01% 1667
2021
Q1 		$14.8M Buy
194,295
+149,824
+337% +$14.3M 0.01% 1370
2020
Q4 		$3.63M Buy
+44,471
New +$2.19M ﹤0.01% 2751
2020
Q3 		– Sell
-338,645
Closed -$9.48M – 4447
2020
Q2 		$9.48M Buy
338,645
+125,540
+59% +$2.71M 0.01% 1251
2020
Q1 		$3.84M Buy
+213,105
New +$4.63M 0.01% 1531

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Millennium Management's BEAM Position: Q1 2026 in Review

Millennium Management reduced its Beam Therapeutics (BEAM) stake by 93% in Q1 2026, selling an estimated $7.75M and leaving 22,234 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #4737.

Millennium Management first reported a position in BEAM in Q1 2020 and has held it in 24 quarters since. The position peaked at $33.1M in Q1 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Millennium Management held 22,234 shares of Beam Therapeutics worth $530K as of Q1 2026.
  • Millennium Management sold 279,416 Beam Therapeutics shares in Q1 2026, an estimated $7.75M.
  • Beam Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4737 holding.
  • Millennium Management first reported a position in Beam Therapeutics in Q1 2020 and has held it in 24 quarters since.
  • Millennium Management's Beam Therapeutics position peaked at $33.1M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.